Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Brain white matter abnormality in a newborn infant with congenital adrenal hyperplasia.

Kaga A, Saito-Hakoda A, Uematsu M, Kamimura M, Kanno J, Kure S, Fujiwara I.

Clin Pediatr Endocrinol. 2013 Oct;22(4):77-81. doi: 10.1292/cpe.22.77. Epub 2013 Oct 26.

2.

Brain white matter impairment in congenital adrenal hyperplasia.

Bergamaschi R, Livieri C, Uggetti C, Candeloro E, Egitto MG, Pichiecchio A, Cosi V, Bastianello S.

Arch Neurol. 2006 Mar;63(3):413-6.

PMID:
16540460
3.

Congenital adrenal hyperplasia and brain magnetic resonance imaging abnormalities.

Samia YM, Mahdi K, Baha Z, Saida JO, Tahar SM, Habib SM.

Clin Pediatr Endocrinol. 2010 Oct;19(4):109-13. doi: 10.1297/cpe.19.109. Epub 2010 Dec 29.

4.

Early occurrence of cerebral white matter abnormality detected in a neonate with salt-wasting congenital adrenal hyperplasia.

Winfeld M, Patel P, Shah B, Nass R, Milla S.

J Pediatr Endocrinol Metab. 2013;26(1-2):13-7. doi: 10.1515/jpem-2012-0154.

PMID:
23382298
5.

Brain magnetic resonance imaging findings in adult patients with congenital adrenal hyperplasia: Increased frequency of white matter impairment and temporal lobe structures dysgenesis.

Mnif MF, Kamoun M, Mnif F, Charfi N, Kallel N, Rekik N, Naceur BB, Fourati H, Daoud E, Mnif Z, Sfar MH, Younes-Mhenni S, Sfar MT, Hachicha M, Abid M.

Indian J Endocrinol Metab. 2013 Jan;17(1):121-7. doi: 10.4103/2230-8210.107833.

6.

[Values of diffusion-weighted magnetic resonance imaging in the early detection of periventricular leukomalacia in preterm infants].

Fu JH, Xue XD, Fan GG, You K, Ren Y.

Zhonghua Er Ke Za Zhi. 2008 May;46(5):354-8. Chinese.

PMID:
19099752
7.

Defining the nature of the cerebral abnormalities in the premature infant: a qualitative magnetic resonance imaging study.

Inder TE, Wells SJ, Mogridge NB, Spencer C, Volpe JJ.

J Pediatr. 2003 Aug;143(2):171-9.

PMID:
12970628
8.

Newborn screening for congenital adrenal hyperplasia in New York State.

Pearce M, DeMartino L, McMahon R, Hamel R, Maloney B, Stansfield DM, McGrath EC, Occhionero A, Gearhart A, Caggana M, Tavakoli NP.

Mol Genet Metab Rep. 2016 Mar 12;7:1-7. doi: 10.1016/j.ymgmr.2016.02.005. eCollection 2016 Jun.

9.

No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.

Hird BE, Tetlow L, Tobi S, Patel L, Clayton PE.

Arch Dis Child. 2014 Feb;99(2):158-64. doi: 10.1136/archdischild-2013-304473. Epub 2013 Nov 13.

PMID:
24225272
10.

Congenital adrenal hyperplasia and multiple sclerosis: is there an increased risk of multiple sclerosis in individuals with congenital adrenal hyperplasia?

Bergamaschi R, Livieri C, Candeloro E, Uggetti C, Franciotta D, Cosi V.

Arch Neurol. 2004 Dec;61(12):1953-5.

PMID:
15596619
11.

Placental pathology in full-term infants with hypoxic-ischemic neonatal encephalopathy and association with magnetic resonance imaging pattern of brain injury.

Harteman JC, Nikkels PG, Benders MJ, Kwee A, Groenendaal F, de Vries LS.

J Pediatr. 2013 Oct;163(4):968-95.e2. doi: 10.1016/j.jpeds.2013.06.010. Epub 2013 Jul 25.

PMID:
23891350
12.

Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.

Therrell BL Jr, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S.

Pediatrics. 1998 Apr;101(4 Pt 1):583-90.

PMID:
9521938
13.
14.

Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study.

Tsuji A, Konishi K, Hasegawa S, Anazawa A, Onishi T, Ono M, Morio T, Kitagawa T, Kashimada K.

BMC Pediatr. 2015 Dec 15;15:209. doi: 10.1186/s12887-015-0529-y.

15.

Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.

Allen DB, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A.

J Pediatr. 1997 Jan;130(1):128-33.

PMID:
9003862
16.

Nationwide neonatal screening for congenital adrenal hyperplasia in sweden: a 26-year longitudinal prospective population-based study.

Gidlöf S, Wedell A, Guthenberg C, von Döbeln U, Nordenström A.

JAMA Pediatr. 2014 Jun;168(6):567-74. doi: 10.1001/jamapediatrics.2013.5321.

PMID:
24733564
17.

Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.

Balsamo A, Cacciari E, Piazzi S, Cassio A, Bozza D, Pirazzoli P, Zappulla F.

Pediatrics. 1996 Sep;98(3 Pt 1):362-7.

PMID:
8784357
18.

Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.

Varness TS, Allen DB, Hoffman GL.

J Pediatr. 2005 Oct;147(4):493-8.

PMID:
16227036
19.
20.

Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.

Cavarzere P, Samara-Boustani D, Flechtner I, Dechaux M, Elie C, Tardy V, Morel Y, Polak M.

Eur J Endocrinol. 2009 Aug;161(2):285-92. doi: 10.1530/EJE-09-0145. Epub 2009 May 18.

Supplemental Content

Support Center